Comments

Acumen Pharmaceuticals Stock Price, Quotes and Forecasts

Q: What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ABOSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.21

0.065.22%

At close: -

$1.25

0.043.28%

After Hours: 7:29 AM EDT

Acumen Pharmaceuticals (ABOS) Forecast

News Earnings Acumen Pharmaceuticals (ABOS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Acumen Pharmaceuticals Stock Price, Quotes and Forecasts | NASDAQ:ABOS | Benzinga

Explore Acumen Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ABOS.

Open	$1.12
Close	$1.21
Volume / Avg.	179.84K / 321.94K
Day Range	$1.10 - $1.21
52 Wk Range	1.15 - 5.09
Market Cap	$75.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	3.9%
Days to Cover	6.85

Recent News

Halozyme's ENHANZE Product Gets New Patent Grant in EU

Halozyme Therapeutics (NASDAQ: HALO) announced that it has been granted a new patent in the EU that covers the ENHANZE rHuPH20 product, which is produced using the company's proprietary ENHANZE manufacturing methods.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.12
Close	$1.21
Volume / Avg.	179.84K / 321.94K
Day Range	$1.10 - $1.21
52 Wk Range	1.15 - 5.09
Market Cap	$75.08M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	32
Short Interest	3.9%
Days to Cover	6.85

About Acumen Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Acumen Pharmaceuticals (ABOS) stock?

You can purchase shares of Acumen Pharmaceuticals (NASDAQ:ABOS) through any online brokerage.

View our list of the best stock brokerages

Who are Acumen Pharmaceuticals (ABOS) competitors?

Other companies in Acumen Pharmaceuticals’s space includes: Inozyme Pharma (NASDAQ:INZY), Burning Rock Biotech (NASDAQ:BNR), Armata Pharmaceuticals (AMEX:ARMP), Citius Oncology (NASDAQ:CTOR) and Inovio Pharmaceuticals (NASDAQ:INO).

What is the forecast, or price target, for Acumen Pharmaceuticals (ABOS) stock?

Acumen Pharmaceuticals has a consensus price target of $12.25.

What is the current price for Acumen Pharmaceuticals (ABOS)?

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $1.2497 last updated March 4, 2025 at 7:29 AM EST.

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

There are no upcoming dividends for Acumen Pharmaceuticals.

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

Acumen Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 13, 2025.

Is Acumen Pharmaceuticals (ABOS) going to split?

There is no upcoming split for Acumen Pharmaceuticals.

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

Acumen Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.